0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.72%
Revenue growth of 24.72% while 0455.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
-76.02%
Negative gross profit growth while 0455.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-56.61%
Negative EBIT growth while 0455.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.79%
Negative operating income growth while 0455.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-32.02%
Negative net income growth while 0455.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.52%
Negative EPS growth while 0455.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-32.52%
Negative diluted EPS growth while 0455.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 0455.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while 0455.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while 0455.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-94.79%
Negative 10Y revenue/share CAGR while 0455.HK stands at 315.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-72.16%
Negative 5Y CAGR while 0455.HK stands at 53.09%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-8.24%
Negative 3Y CAGR while 0455.HK stands at 27.39%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 0455.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 0455.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
100.00%
3Y OCF/share CAGR of 100.00% while 0455.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-312.21%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-557.81%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
20.57%
Positive short-term CAGR while 0455.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
-55.77%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-54.84%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-48.30%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.48%
Firm’s AR is declining while 0455.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-13.61%
Negative asset growth while 0455.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.92%
We have a declining book value while 0455.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-34.53%
We’re deleveraging while 0455.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
97.32%
R&D growth of 97.32% while 0455.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
3.37%
SG&A growth of 3.37% while 0455.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.